Pharma R&D Returns Surge in 2024, Driven by GLP-1 Therapies, Despite Rising Costs
What You Should Know:
– The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
– This…
Continue Reading